Kenko Imalytics

Kenko Imalytics, a spin-off of the Universitat Politècnica de València founded in 2021 and supported by the GIEM-SATRD group, develops a SaaS platform for “virtual biopsies” based on multivariate statistical algorithms (LV-MSPM) applied to magnetic resonance images of the prostate and breast; this solution generates probability maps that facilitate a clear, precise, and rapid clinical interpretation.

The technology optimizes the diagnostic workflow of radiologists and oncologists, reducing the time it takes to prepare reports, improving the sensitivity and specificity of the process, and adapting to different scanners. With more than a decade of research supported by scientific publications, Kenko has been recognized with awards such as the Ideas UPV 2022 and has completed investment rounds to boost its expansion.

This digital tool, accessible and clinically validated, converts the power of statistical research into a tangible improvement for personalized medicine. Its mission is to provide confidence and time to patients and professionals, contributing to earlier, safer, and more efficient cancer care.